Peripheral nerves regenerate after injury. Central nervous system axons do not. For decades we blamed the environment—myelin inhibitors, glial scar, missing growth factors. But the deeper problem is that adult CNS neurons have forgotten how to grow.
During development, neurons extend axons readily, navigating complex environments to find targets. After maturation, this capacity is silenced through epigenetic changes and transcriptional reprogramming. The neuron is not blocked by external barriers; it has lost the internal programs for axon growth.
This explains a key observation: if you crush a peripheral nerve twice, the second regeneration is faster. The conditioning lesion awakens growth programs. But no amount of conditioning lesions in the CNS produces the same effect—the neurons cannot reactivate the necessary genes.
The molecular brakes—PTEN, SOCS3, KLF transcription factors—are developmentally regulated. Delete PTEN in adult retinal ganglion cells and they regenerate axons into the optic nerve. The environment was permissible all along; the neurons just needed permission to grow.
The clinical implication shifts. We have been trying to make the CNS environment more like the PNS—scar suppression, myelin clearance. But if the neurons themselves are the bottleneck, we need intracellular interventions. Gene therapies that reactivate developmental growth programs may work even in scarred, inhibitor-rich environments.
The question is which growth programs matter most, and how to turn them back on without triggering cancer or developmental chaos.